Literature DB >> 33858813

Long-term Clinical Outcomes of Repeat Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: A Case Series.

Markus Grabbert1, August Sigle2, Larissa Lang2, Moritz von Büren2, Michael Mix3, Constantinos Zamboglou4, Christian Gratzke2, Wolfgang Schultze-Seemann2, Cordula A Jilg2.   

Abstract

This case series highlights the role of repeat salvage lymph node dissection (sLND) for nodal-recurrent prostate cancer. We provide a descriptive analysis of ten patients who underwent sLND in a total of 23 surgeries (mean 2.3 sLNDs per patient) and their long-term follow-up (median of 158 mo after radical prostatectomy). A complete prostate-specific antigen response was observed in nine/23 cases (39.1%), and an incomplete response in 14 (60.9%). Analysis by anatomical location revealed a trend towards more distant metastases on repeat surgery, with only three in-field recurrences in patients with previously positive nodes. Repeat sLND can be surgically challenging, and major intraoperative complications were observed in three/23 cases (13.0%). Repeat sLND for patients with nodal-recurrent prostate cancer seems to be a feasible treatment option, albeit only in carefully selected patients. Nevertheless, it remains a highly experimental approach with unclear oncological benefit.
Copyright © 2021 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Nodal-recurrent prostate cancer; Oncological outcome; Salvage lymph node dissection

Mesh:

Year:  2021        PMID: 33858813     DOI: 10.1016/j.euf.2021.03.025

Source DB:  PubMed          Journal:  Eur Urol Focus        ISSN: 2405-4569


  2 in total

Review 1.  Impact of human placental derivative allografts on functional and oncological outcomes after radical prostatectomy: a literature review.

Authors:  Jonathan Noël; Subuhee Ahmed; Anya Mascarenhas; Daniel Stirt; Marcio Moschovas; Ela Patel; Sunil Reddy; Seetharam Bhat; Travis Rogers; Vipul Patel
Journal:  J Robot Surg       Date:  2022-06-18

Review 2.  [Opportunities and risks of telemedicine in urology].

Authors:  Christian Wülfing
Journal:  Urologe A       Date:  2022-02-07       Impact factor: 0.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.